Synlab markets €550 million seven-year senior secured notes

By Abigail W. Adams

Portland, Me., Dec. 7 – Synlab AG parent company Ephios Subco 3 is in the market with a €550 million offering of seven-year senior secured notes (B2/B+/B+) with investor meetings scheduled for Thursday and Friday, according to a market source.

Deutsche Bank Securities Inc., Barclays, BNP Paribas Securities Corp., Citigroup Global Markets Inc., Credit Agricole CIB, Mizuho Securities USA Inc. and Natixis Securities Americas LLC are joint global coordinators and bookrunners for the Rule 144A and Regulation S offering.

Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., ING Financial Markets LLC, RBI, Santander Investment Securities Inc., SMBC Nikko Securities America Inc., Standard Chartered Bank and UniCredit Capital Markets LLC are also joint bookrunners.

Proceeds, together with a concurrent €900 million seven-year term loan B, will be used to fund the acquisition of Synlab AG by Cinven for €10 per share and to repay an existing term loan A due 2026.

Synlab is a Munich-based medical diagnostics services provider.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.